SCHEMBL467903

SCHEMBL467903

CCOC([SiH3])(CNC1CCCCC1)OCC

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 5/20 0.36
POLB P06746 1/20 0.36
ALDH1A1 P00352 3/20 0.34
CYP1A2 P05177 1/20 0.33
CYP2D6 P10635 1/20 0.33
CYP2C19 P33261 1/20 0.33
MEN1 O00255 1/20 0.33
GAA P10253 1/20 0.33
HTT P42858 1/20 0.33
KMT2A Q03164 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
THRB P10828 1/20 0.33
ATM Q13315 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
NPSR1 Q6W5P4 1/20 0.31
MMP1 P03956 1/20 0.31
MMP2 P08253 1/20 0.31
EPHX2 P34913 1/20 0.31
TSHR P16473 1/20 0.31
MITF O75030 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16197508 0.82 KDM4E (0.39) KDM4EPOLBALDH1A1CYP1A2CYP2D6
SCHEMBL17350253 0.82 KDM4E (0.33) KDM4EPOLBALDH1A1
SCHEMBL56306 0.81 KDM4E (0.38) KDM4EPOLBALDH1A1MEN1GAA
SCHEMBL1455086 0.77 KDM4E (0.34) KDM4EPOLBALDH1A1CYP1A2CYP2D6
SCHEMBL16197509 0.71 NPSR1 (0.33) KDM4EPOLBALDH1A1CYP1A2CYP2D6
SCHEMBL17373497 0.71 KDM4E (0.36) KDM4EALDH1A1MEN1KMT2ATHRB
SCHEMBL4776115 0.71 ALDH1A1 (0.39) KDM4EPOLBALDH1A1CYP1A2CYP2D6
SCHEMBL18177820 0.69 KDM4E (0.43) KDM4EALDH1A1CYP1A2CYP2D6CYP2C19
SCHEMBL11053891 0.69 KDM4E (0.43) KDM4EALDH1A1CYP1A2CYP2D6CYP2C19
SCHEMBL21164693 0.68 KDM4E (0.43) KDM4EPOLBALDH1A1CYP1A2CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 541 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4700098-A1 HIGH-SOLIDS TRIGLYCERIDE OIL BASED WOOD COATING COMPOSITIONS SPSV B.V. (NL) 2026-02-25 EP claimed
EP-3081612-B1 PHOTOCURABLE COMPOSITION HAVING ADHESIVE PROPERTIES CEMEDINE CO LTD (JP) 2018-11-14 EP claimed
US-8815985-B2 Curable composition KANEKA CORPORATION (JP) 2014-08-26 US claimed
EP-4727982-A1 PRIMER COMPOSITION, ADHESIVE SYSTEM, AND RELATED PROCESSES 3M Innovative Properties Company (US) 2026-04-22 EP disclosed
EP-3585851-B1 AIR AND WATER BARRIER ARTICLE INCLUDING INELASTIC POROUS LAYER 3M INNOVATIVE PROPERTIES COMPANY (US) 2026-04-01 EP disclosed
US-12584022-B2 Solvochromic effect pigments, method of production and use thereof ECKART GMBH (DE) 2026-03-24 US disclosed
EP-4703405-A1 CRYSTALLINE POLYOXYALKYLENE-BASED POLYMER AND CURABLE COMPOSITION COMPRISING SAME Kaneka Corporation (JP) 2026-03-04 EP disclosed
EP-4700098-A1 HIGH-SOLIDS TRIGLYCERIDE OIL BASED WOOD COATING COMPOSITIONS SPSV B.V. (NL) 2026-02-25 EP disclosed
EP-4692247-A1 CURABLE COMPOSITION KANEKA CORPORATION (JP) 2026-02-11 EP disclosed
US-12545691-B2 Tertiary hydroxyl functional alkoxysilanes and methods for preparing thereof HENKEL AG & CO. KGAA (DE) 2026-02-10 US disclosed
US-20260022211-A1 CURABLE COMPOSITION KANEKA CORPORATION (JP) 2026-01-22 US disclosed
EP-1746134-A1 CURABLE COMPOSITION WITH IMPROVED CURABILITY AND ADHESIVENESS Kaneka Corporation (JP) 2007-01-24 EP disclosed
EP-1736511-A1 CURABLE COMPOSITION KANEKA CORPORATION (JP) 2006-12-27 EP disclosed
EP-1734079-A1 SINGLE-COMPONENT CURABLE COMPOSITION Kaneka Corporation (JP) 2006-12-20 EP disclosed
EP-1731574-A1 SINGLE-COMPONENT CURABLE COMPOSITION KANEKA CORPORATION (JP) 2006-12-13 EP disclosed
EP-1731573-A1 CURABLE COMPOSITION KANEKA CORPORATION (JP) 2006-12-13 EP disclosed
US-20060252903-A1 Curing composition KANEKA CORPORATION 2006-11-09 US disclosed
EP-1717240-A1 Organoalkoxysilanes for use in moisture curable compositions Sika Technology AG (CH) 2006-11-02 EP disclosed
US-20060089432-A1 Curable composition KANEKA CORPORATION (JP) 2006-04-27 US disclosed
EP-1624027-A1 CURING COMPOSITION KANEKA CORPORATION (JP) 2006-02-08 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12545691-B2 Tertiary hydroxyl functional alkoxysilanes and methods for preparing thereof HCCS, EGLN1, RRS1 KDM4E 3603/4885POLB 3103/4885ALDH1A1 439/4885
US-12584022-B2 Solvochromic effect pigments, method of production and use thereof PPOX, TDO2, SCO2 KDM4E 3573/4885POLB 3427/4885ALDH1A1 2915/4885
US-20260022211-A1 CURABLE COMPOSITION H1-4, H1-0, H1-2 KDM4E 256/4885POLB 974/4885ALDH1A1 2939/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.